Colin McArthur
Overview
Explore the profile of Colin McArthur including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
8163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McTavish S, Kim A, Kvalsvig A, Atkinson J, McArthur C, Baker M
N Z Med J
. 2025 Feb;
138(1610):13-30.
PMID: 40014768
Aim: To characterise patient mortality risk following intensive care unit (ICU) admitted community-acquired sepsis (CAS) in Aotearoa New Zealand (Aotearoa), comparing in-hospital and post-discharge mortality and associated risk factors. Methods:...
2.
Daneman N, Rishu A, Pinto R, Rogers B, Rogers B, Shehabi Y, et al.
N Engl J Med
. 2024 Nov;
392(11):1065-1078.
PMID: 39565030
Background: Bloodstream infections are associated with substantial morbidity and mortality. Early, appropriate antibiotic therapy is important, but the duration of treatment is uncertain. Methods: In a multicenter, noninferiority trial, we...
3.
Parke R, McGuinness S, Cavadino A, Cowdrey K, Bates S, Bihari S, et al.
Crit Care Resusc
. 2024 Oct;
26(3):161-168.
PMID: 39355498
Objective: Acute respiratory distress syndrome (ARDS) is associated with significant mortality, morbidity, and cost. We aimed to describe characteristics and management of adult patients admitted to intensive care units (ICUs)...
4.
Maze M, Williman J, Anstey R, Best E, Bhally H, Bryce A, et al.
IJID Reg
. 2024 Sep;
12:100424.
PMID: 39281192
Objectives: COVID-19 severity prediction scores need further validation due to evolving COVID-19 illness. We evaluated existing COVID-19 risk prediction scores in Aotearoa New Zealand, including for Māori and Pacific peoples...
5.
Taylor A, Best E, Walls T, Webb R, Bhally H, Bryce A, et al.
IJID Reg
. 2024 Aug;
12:100408.
PMID: 39185270
Objectives: This multicenter cohort study describes Aotearoa New Zealand children hospitalized during the country's first wave of sustained SARS-CoV-2 transmission, Omicron variant. Methods: Children younger than 16 years, hospitalized for...
6.
Huang Q, Turner N, Wood T, Anglemyer A, McIntyre P, Aminisani N, et al.
Influenza Other Respir Viruses
. 2024 Feb;
18(2):e13247.
PMID: 38350715
Background: New Zealand's (NZ) complete absence of community transmission of influenza and respiratory syncytial virus (RSV) after May 2020, likely due to COVID-19 elimination measures, provided a rare opportunity to...
7.
Axfors C, Schmitt A, Janiaud P, Vant Hooft J, Abd-Elsalam S, Abdo E, et al.
Nat Commun
. 2024 Feb;
15(1):1075.
PMID: 38316844
No abstract available.
8.
Daubney E, DUrso S, Cuellar-Partida G, Rajbhandari D, Peach E, De Guzman E, et al.
Crit Care Explor
. 2024 Jan;
6(1):e1030.
PMID: 38239409
Objectives: We sought to assess whether genetic associations with metabolite concentrations in septic shock patients could be used to identify pathways of potential importance for understanding sepsis pathophysiology. Design: Retrospective...
9.
Skrifvars M, Luethi N, Bailey M, French C, Nichol A, Trapani T, et al.
Intensive Care Med
. 2023 Jul;
49(7):831-839.
PMID: 37405413
Purpose: Recombinant erythropoietin (EPO) administered for traumatic brain injury (TBI) may increase short-term survival, but the long-term effect is unknown. Methods: We conducted a pre-planned long-term follow-up of patients in...
10.
Goligher E, Lawler P, Jensen T, Talisa V, Berry L, Lorenzi E, et al.
JAMA
. 2023 Mar;
329(13):1066-1077.
PMID: 36942550
Importance: Randomized clinical trials (RCTs) of therapeutic-dose heparin in patients hospitalized with COVID-19 produced conflicting results, possibly due to heterogeneity of treatment effect (HTE) across individuals. Better understanding of HTE...